Advanced search
Publication Cover
Postgraduate Medicine Volume 121, 2009 - Issue 6
Submit an article Journal homepage
72
Views
28
CrossRef citations to date
0
Altmetric
Clinical Focus: Metabolic Syndrome and Related Conditions

DPP-4 Inhibitors in Clinical Practice

Anna I. Palalau Department of Diabetes and Endocrinology, Heart of England NHS Foundation Trust, Birmingham, UK
, MRCP,
Abd A. Tahrani Department of Diabetes and Endocrinology, Heart of England NHS Foundation Trust, Birmingham, UK; Center of Endocrinology, Diabetes and Metabolism, University of Birmingham, Birmingham, UKCorrespondence[email protected]
, MD, MRCP, MMedSci,
Milan K. Piya Department of Diabetes and Endocrinology, Heart of England NHS Foundation Trust, Birmingham, UK; Center of Endocrinology, Diabetes and Metabolism, University of Birmingham, Birmingham, UK
, MRCP &
Anthony H. Barnett Department of Diabetes and Endocrinology, Heart of England NHS Foundation Trust, Birmingham, UK; Center of Endocrinology, Diabetes and Metabolism, University of Birmingham, Birmingham, UK
, MD, FRCP
Pages 70-100 | Published online: 13 Mar 2015

Citations (28)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Hiroyuki Konya, Yuzo Yano, Satoshi Matsutani, Taku Tsunoda, Takashi Ikawa, Yoshiki Kusunoki, Toshihiro Matsuo, Masayuki Miuchi, Tomoyuki Katsuno, Tomoya Hamaguchi, Jun-ichiro Miyagawa & Mitsuyoshi Namba. (2014) Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients. Therapeutics and Clinical Risk Management 10, pages 547-558.
Read now
CY Pan & XL Wang. (2013) Profile of vildagliptin in type 2 diabetes: efficacy, safety, and patient acceptability. Therapeutics and Clinical Risk Management 9, pages 247-257.
Read now
Jennifer B. Green. (2012) The Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus: Cardiovascular Safety. Postgraduate Medicine 124:4, pages 54-61.
Read now
André J Scheen. (2011) Linagliptin for the treatment of type 2 diabetes (pharmacokinetic evaluation). Expert Opinion on Drug Metabolism & Toxicology 7:12, pages 1561-1576.
Read now
Biju Jose, Abd A Tahrani, Milan K Piya & Anthony H Barnett. (2010) Exenatide once weekly: clinical outcomes and patient satisfaction. Patient Preference and Adherence 4, pages 313-324.
Read now

Articles from other publishers (23)

Kunika Saini, Smriti Sharma & Yousuf Khan. (2023) DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature. Frontiers in Molecular Biosciences 10.
Crossref
Xiaoliang Sun, Ziyuan Zhang, Meiyan Liu, Peng Zhang, Liqin Nie, Yuqing Liu, Ye Chen, Fengjiao Xu, Zhonghua Liu & Youlin Zeng. (2022) Small-molecule albumin ligand modification to enhance the anti-diabetic ability of GLP-1 derivatives. Biomedicine & Pharmacotherapy 148, pages 112722.
Crossref
Enrique Gallego-Colon, Wojciech Wojakowski & Tomasz Francuz. (2018) Incretin drugs as modulators of atherosclerosis. Atherosclerosis 278, pages 29-38.
Crossref
Ning Li, Li-Jun Wang, Bo Jiang, Xiang-qian Li, Chuan-long Guo, Shu-ju Guo & Da-Yong Shi. (2018) Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus. European Journal of Medicinal Chemistry 151, pages 145-157.
Crossref
Nages Nagaratnam, Kujan Nagaratnam & Gary CheukNages Nagaratnam, Kujan Nagaratnam & Gary Cheuk. 2018. Geriatric Diseases. Geriatric Diseases 403 417 .
Toshiharu Nagatsu. (2016) Prolyl oligopeptidase and dipeptidyl peptidase II/dipeptidyl peptidase IV ratio in the cerebrospinal fluid in Parkinson’s disease: historical overview and future prospects. Journal of Neural Transmission 124:6, pages 739-744.
Crossref
Lara Batičić Pučar, Antonijo Grčić, Ester Pernjak Pugel, Dijana Detel & Jadranka Varljen. (2017) Wound healing process and dipeptidyl peptidase IV. Medicina fluminensis 53:1, pages 4-15.
Crossref
Nages Nagaratnam, Kujan Nagaratnam & Gary CheukNages Nagaratnam, Kujan Nagaratnam & Gary Cheuk. 2017. Geriatric Diseases. Geriatric Diseases 1 15 .
Abd A. Tahrani, Anthony H. Barnett & Clifford J. Bailey. (2016) Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus. Nature Reviews Endocrinology 12:10, pages 566-592.
Crossref
Abdallah Al Eyadeh & Paul E Jennings. (2015) New pharmacological approaches to diabetes management. Practice Nursing 26:3, pages 140-146.
Crossref
Hiroyuki Konya. (2015) Asymmetric dimethylarginine, a biomarker of cardiovascular complications in diabetes mellitus. World Journal of Experimental Medicine 5:2, pages 110.
Crossref
Tegan P. Stockdale & Craig M. Williams. (2015) Pharmaceuticals that contain polycyclic hydrocarbon scaffolds. Chemical Society Reviews 44:21, pages 7737-7763.
Crossref
Margarita Juárez-Montiel, J. Antonio Ibarra, Griselda Chávez-Camarillo, César Hernández-Rodríguez & Lourdes Villa-Tanaca. (2014) Molecular Cloning and Heterologous Expression in Pichia pastoris of X-Prolyl-dipeptidyl Aminopeptidase from Basidiomycete Ustilago maydis. Applied Biochemistry and Biotechnology 172:5, pages 2530-2539.
Crossref
Genovefa D. Kolovou, Vana Kolovou & Sophie Mavrogeni. (2014) We Are Ageing. BioMed Research International 2014, pages 1-12.
Crossref
Lara Pučar, Dijana Detel & Jadranka Varljen. (2012) Dipeptidyl Peptidase IV in Inflammatory Bowel Diseases (DPP IV/CD26). Archives of Industrial Hygiene and Toxicology 63:1, pages 75-100.
Crossref
Jennifer B. Marks. 2012. Atlas of Diabetes. Atlas of Diabetes 167 191 .
Juergen Sandow. 2003. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry.
Deanna S. Kania, Jasmine D. Gonzalvo & Zachary A. Weber. (2011) Saxagliptin: A Clinical Review in the Treatment of Type 2 Diabetes Mellitus. Clinical Therapeutics 33:8, pages 1005-1022.
Crossref
Chiara NedianiLaura RaimondiElisabetta BorchiElisabetta Cerbai. (2011) Nitric Oxide/Reactive Oxygen Species Generation and Nitroso/Redox Imbalance in Heart Failure: From Molecular Mechanisms to Therapeutic Implications. Antioxidants & Redox Signaling 14:2, pages 289-331.
Crossref
Hyun Jeong JeonTae Keun Oh. (2011) Comparison of Vildagliptin-Metformin and Glimepiride-Metformin Treatments in Type 2 Diabetic Patients. Diabetes & Metabolism Journal 35:5, pages 529.
Crossref
John B. Buse, Kenneth S. Polonsky & Charles F. Burant. 2011. Williams Textbook of Endocrinology. Williams Textbook of Endocrinology 1371 1435 .
Abd A. Tahrani & Anthony H. Barnett. (2011) Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes. Diabetes Therapy 1:2, pages 45-56.
Crossref
Gillian M. Keating. (2010) Vildagliptin. Drugs 70:16, pages 2089-2112.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.